<searchTitle>Schedules of Controlled Substances: Placement of Ethylphenidate in Schedule I; Federal Register Vol. 89, Issue </searchTitle>
<granuleClass>RULE</granuleClass>
<accessId>2024-24083</accessId>
<agency order="1">DEPARTMENT OF JUSTICE</agency>
<agency order="2">Drug Enforcement Administration</agency>
<effectiveDate>2024-11-21</effectiveDate>
<departmentDoc>Docket No. DEA-1142</departmentDoc>
<billingCode>4410-09-P</billingCode>
<frDocNumber>2024-24083</frDocNumber>
<action>Final rule.</action>
<summary>With the issuance of this final rule, the Drug Enforcement Administration places ethylphenidate (chemical name: ethyl 2-phenyl-2- (piperidin-2-yl)acetate), including its salts, isomers, and salts of isomers, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. When finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle ethylphenidate.</summary>
<dates>Effective date: November 21, 2024.</dates>
<contact>Dr. Terrence L. Boos, Drug and Chemical Evaluation Section, Diversion Control Division, Drug Enforcement Administration; Telephone: (571) 362-3249.</contact>
<cfr title="21">
<part number="1308"/>
<subject>Administrative Practice and Procedure</subject>
<subject>Drug Traffic Control</subject>
<subject>Reporting and Recordkeeping Requirements</subject>
...</cfr>
<tocSubject1>Schedules of Controlled Substances</tocSubject1>
<tocDoc>Placement of Ethylphenidate in Schedule I, </tocDoc>
<urlRef>https://apps.deadiversion.usdoj.gov/webforms2/spring/main?execution=e1s2</urlRef>
<urlRef>https://www.regulations.gov</urlRef>